≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Myeloid leukaemia

Endpoint Browser PheWeb

CD2_MYELOID_LEUKAEMIA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C92
  • Hospital discharge: ICD-9 — 205
  • Hospital discharge: ICD-8 — 205
  • Cause of death: ICD-10 — C92
  • Cause of death: ICD-9 — 205
  • Cause of death: ICD-8 — 205

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C81-C96
Name in latin
Leuc(h)aemia myeloides

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 922 405 517
Unadjusted period prevalence (%) 0.19 0.14 0.23
Median age at first event (years) 63.95 58.58 68.16

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
912
Matched controls
9120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XW000
NOMESCO Finland
Bone marrow biopsy
137.4
323.0
518
86
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
323.0
304
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
911.5
323.0
696
32
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
323.0
567
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
300.0
271
*
WW500
NOMESCO Finland
Blood transfusion
49.6
219.6
266
75
189
Kela drug reimbursment
Imatinib
+∞
200.6
185
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
51.7
189.1
227
58
L03AA02
ATC
filgrastim; parenteral
1055.3
181.8
172
*
L01XE01
ATC
[U] imatinib; oral
+∞
171.4
159
*
A04AA01
ATC
ondansetron; systemic, rectal
47.2
168.5
206
56
127
Kela drug reimbursment
Transplant complication
53.8
137.7
164
37
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
133.7
125
*
M04AA01
ATC
allopurinol; systemic
7.6
130.4
362
727
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
297.2
128.7
128
5
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
700.2
126.6
122
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
119.4
112
*
L01XX05
ATC
hydroxycarbamide; oral
60.5
119.2
139
27
A05AA02
ATC
ursodeoxycholic acid; oral
46.3
118.3
145
37
R50.9
ICD-10 Finland
Fever, unspecified
7.3
110.2
306
592
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.9
103.3
297
596
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.5
99.1
263
467
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
97.7
92
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
12.1
96.0
185
188
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
92.3
87
*
316
Kela drug reimbursment
Imatinib
+∞
86.9
82
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.0
86.1
174
192
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
88.3
86.0
95
12
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
83.6
79
*
J05AB11
ATC
valaciclovir; oral
6.0
81.2
256
557
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
80.4
76
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
79.3
75
*
H02AB02
ATC
dexamethasone; systemic
34.4
73.6
96
31
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
268.0
73.5
74
*
J01MA12
ATC
levofloxacin; systemic
4.6
72.2
306
909
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
13.4
70.3
127
109
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
70.1
530
2578
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
51.3
70.0
84
18
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
68.6
65
*
ZX120
NOMESCO Finland
Intravenous
7.3
67.9
176
288
Z51.5
ICD-10 Finland
Palliative care
16.6
66.5
109
74
JN4BD
NOMESCO Finland
Extensive body CT
8.3
64.7
153
217
L01BB02
ATC
mercaptopurine; oral
45.4
64.4
79
19
152
Kela drug reimbursment
Nilotinib
+∞
64.3
61
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.6
64.2
148
201
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
61.1
58
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
60.1
57
*
D64.9
ICD-10 Finland
Anaemia, unspecified
5.2
59.0
207
491
J02AC03
ATC
voriconazole; systemic
317.0
59.0
59
*
WW200
NOMESCO Finland
Immunization
13.9
56.8
100
80
D70.89
ICD-10 Finland
Neutropenic splenomegaly
35.9
56.7
73
22
ZX112
NOMESCO Finland
Subcutaneous
46.6
56.6
69
16
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
27.9
56.1
77
30
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
55.8
53
*
L04AD01
ATC
ciclosporin; systemic
19.3
55.8
86
49
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
39.1
54.7
69
19
N02AA05
ATC
oxycodone; systemic
4.8
54.5
204
515
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
53.7
51
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
53.7
51
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
194.8
53.6
55
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.7
52.9
203
525
A04AA02
ATC
granisetron; systemic, transdermal
+∞
52.6
50
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
51.5
49
*
150
Kela drug reimbursment
Dasatinib
+∞
51.5
49
*
A41.9
ICD-10 Finland
Sepsis, unspecified
9.1
50.6
111
137
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
18.3
50.4
79
47
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.7
50.3
123
181
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
49.4
47
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
48.4
46
*
L01XX28
ATC
[D] imatinib; oral
+∞
48.4
46
*
L01XE06
ATC
[U] dasatinib; systemic
+∞
46.2
44
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
48.6
45.6
55
12
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
103.4
45.2
49
5
JN4AD
NOMESCO Finland
Body CT examination
9.4
44.8
96
113
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
44.4
230
771
L01XE08
ATC
[U] nilotinib; oral
+∞
43.1
41
*
212
Kela drug reimbursment
Gout
11.9
42.1
79
72
ZX090
NOMESCO Finland
Other technic of radiotherapy
153.9
42.1
44
*
115
Kela drug reimbursment
Breast cancer
+∞
42.0
40
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
13.5
42.0
74
59
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.4
40.1
71
57
J01MA14
ATC
moxifloxacin; systemic
4.5
39.0
150
380
B73
ICPC
Leukaemia
+∞
37.8
36
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
382.2
37.3
37
*
L04AA06
ATC
mycophenolic acid; systemic
14.4
35.8
61
45
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
35.6
34
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
35.6
34
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
35.3
317
1513
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
34.6
33
*
130
Kela drug reimbursment
Malignant tumour
+∞
34.6
33
*
TGC00
NOMESCO Finland
Bronchial lavation
9.4
34.2
72
82
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.5
33.6
91
153
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
33.5
32
*
328
Kela drug reimbursment
Nilotinib
+∞
33.5
32
*
J05AB01
ATC
aciclovir; systemic
2.9
32.8
244
1032
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
50.8
32.7
39
8
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
56.5
32.5
38
7
116
Kela drug reimbursment
Prostate cancer
+∞
32.5
31
*
L01EA03
ATC
nilotinib; oral
+∞
32.5
31
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
64.1
32.3
37
6
PJA12
NOMESCO Finland
Sentinel node biopsy
327.9
32.1
32
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
32.0
334
1714
H02AB09
ATC
hydrocortisone; systemic
11.8
31.7
59
53
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
323.4
31.0
31
*
L04AA01
ATC
[U] ciclosporin; systemic
12.4
30.8
56
48
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
30.7
129
352
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
21.4
30.7
45
22
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.4
30.6
118
297
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.6
30.1
72
101
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
160.2
29.8
31
*
J02AC04
ATC
posaconazole; systemic
160.2
29.8
31
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.9
29.8
77
121
J02AC01
ATC
fluconazole; systemic
2.3
29.1
360
1994
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
106.8
28.8
31
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
30.4
28.7
38
13
324
Kela drug reimbursment
Dasatinib
+∞
28.3
27
*
WW409
NOMESCO Finland
Other aferesis
149.5
27.8
29
*
1DB06
NOMESCO Finland
NA
+∞
27.2
26
*
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
26.2
25
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
25.6
277
1415
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
25.1
24
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
24.6
135
454
D70.82
ICD-10 Finland
Drug-induced neutropenia
30.1
24.2
32
11
WF002
NOMESCO Finland
Radical radiotherapy
57.7
24.1
28
5
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
24.1
23
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
24.1
23
*
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
24.1
23
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
24.1
23
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
24.1
23
*
L03AB05
ATC
interferon alfa-2b; parenteral
69.4
23.9
27
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
23.7
250
1252
A07AA02
ATC
nystatin; oral
4.3
23.6
91
228
H02AB04
ATC
methylprednisolone; systemic
2.7
23.3
182
775
ZX121
NOMESCO Finland
Central venous catheter
235.6
22.7
23
*
2AX04
NOMESCO Finland
NA
123.1
22.7
24
*
L02BA01
ATC
tamoxifen; oral
123.1
22.7
24
*
L02AE02
ATC
leuprorelin; implant, parenteral
22.0
22.2
32
15
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
22.2
218
1049
H02AB06
ATC
prednisolone; systemic
2.0
22.2
445
2938
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
22.0
21
*
L01EA02
ATC
dasatinib; oral
+∞
22.0
21
*
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
22.0
21
*
1BC07
NOMESCO Finland
NA
+∞
22.0
21
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
22.0
21
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
39.7
21.8
27
7
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
17.1
21.1
33
20
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.9
20
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
20.9
20
*
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
112.6
20.6
22
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
112.6
20.6
22
*
A40.8
ICD-10 Finland
Other streptococcal sepsis
17.8
20.1
31
18
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
19.9
19
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
19.9
19
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
19.9
19
*
B03XA02
ATC
darbepoetin alfa; parenteral
8.9
19.8
42
49
JN4CD
NOMESCO Finland
Very extensive body CT
10.1
19.8
39
40
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.5
19.7
35
29
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
204.2
19.6
20
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
41.0
19.6
24
6
NK6AN
NOMESCO Finland
Total body bone isotope imaging
47.1
19.3
23
5
A41.8
ICD-10 Finland
Other specified sepsis
8.1
19.2
43
55
TPH00
NOMESCO Finland
Phlebotomy
18.7
19.2
29
16
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.3
19.0
51
85
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.1
19.0
109
379
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
18.8
18
*
9860/3-C42.1
ICD-O-3
Myeloid leukemia, NOS, of bone marrow
+∞
18.8
18
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
71.4
18.8
21
*
L02BG04
ATC
letrozole; oral
18.0
18.3
28
16
ZX108
NOMESCO Finland
Inhalation
18.0
18.3
28
16
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
45.0
18.3
22
5
HA1AA
NOMESCO Finland
X-ray mammography
6.4
18.3
48
78
A02BC02
ATC
pantoprazole; systemic
1.9
18.0
561
4211
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
17.8
17
*
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
17.8
17
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
17.8
17
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.0
17.7
44
66
TAB00
NOMESCO Finland
Lumbar puncture
4.4
17.7
66
160
C03CA01
ATC
furosemide; systemic
2.0
17.7
316
1947
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
183.4
17.6
18
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
17.4
17.5
27
16
GD1AD
NOMESCO Finland
Thorax CT examination
4.9
17.1
56
119
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.1
16.9
95
325
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
16.8
62
149
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
16.7
93
313
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
16.7
16
*
L02BB03
ATC
bicalutamide; oral
+∞
16.7
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
16.7
16
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
16.7
16
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
16.7
16
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
16.7
16
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
16.7
87
282
5BA08
NOMESCO Finland
NA
20.5
16.5
24
12
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
16.4
196
1020
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
48.4
16.1
19
*
JN6AD
NOMESCO Finland
CT of torso and neck
21.4
16.0
23
11
B03XA01
ATC
erythropoietin; parenteral
12.5
15.9
28
23
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.5
15.8
29
26
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
15.7
15
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
15.7
15
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
15.7
15
*
170
Kela drug reimbursment
Bosutinib
+∞
15.7
15
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
15.7
15
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
162.6
15.5
16
*
SPAT1088
SPAT
Blood transfusion
29.2
15.2
20
7
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.4
15.2
55
130
B99
ICD-10 Finland
Other and unspecified infectious diseases
6.3
15.1
40
66
B01AB05
ATC
enoxaparin; parenteral
1.9
15.1
254
1510
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
9.1
15.0
31
35
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
14.7
347
2318
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
14.6
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.6
14
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
14.6
14
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
14.6
14
*
Y77
ICPC
Malignant neoplasm prostate
81.4
14.6
16
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
152.3
14.5
15
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
54.2
13.8
16
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
54.2
13.8
16
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
24.2
13.8
19
8
R4110
NOMESCO Finland
Physiotherapy
1.9
13.8
228
1342
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
13.6
13
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
13.6
13
*
1DB07
NOMESCO Finland
NA
+∞
13.6
13
*
B01AB10
ATC
tinzaparin; parenteral
3.9
13.5
55
146
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.2
13.5
41
81
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
142.0
13.5
14
*
D64.8
ICD-10 Finland
Other specified anaemias
7.9
13.4
30
39
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
13.3
93
366
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
10.2
13.0
25
25
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
22.9
12.9
18
8
J01MA02
ATC
ciprofloxacin; systemic
1.7
12.7
349
2415
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
12.6
58
171
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
32.5
12.6
16
5
UJF32
NOMESCO Finland
Coloscopy
1.9
12.6
214
1266
C50.99
ICD-10 Finland
Breast, unspecified
+∞
12.5
12
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
12.5
12
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
12.5
12
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
131.7
12.5
13
*
L03AA04
ATC
NA
131.7
12.5
13
*
D45
ICD-10 Finland
Polycythaemia vera
9.1
12.3
25
28
N02AX02
ATC
tramadol; systemic, rectal
1.7
12.0
357
2517
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
12.0
255
1626
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.8
11.9
77
289
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.0
11.7
37
77
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
11.5
11
*
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
11.5
11
*
L01XE14
ATC
[U] bosutinib; oral
+∞
11.5
11
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.5
11
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
11.5
11
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
11.5
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
121.5
11.4
12
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
11.3
57
182
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
25.4
11.2
15
6
F43.29
ICD-10 Finland
Adaptation disorder UNS
7.5
11.0
25
34
A02BC01
ATC
omeprazole; systemic
1.7
11.0
255
1663
B02.9
ICD-10 Finland
Zoster without complication
2.9
10.8
67
245
A01AB04
ATC
amphotericin B; local oral
3.0
10.7
63
223
6BA02
NOMESCO Finland
NA
28.4
10.7
14
5
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
21.7
10.7
15
7
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
10.5
97
445
1CX01
NOMESCO Finland
NA
111.2
10.4
11
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
111.2
10.4
11
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
10.4
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.4
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.4
10
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
10.4
10
*
360
Kela drug reimbursment
Bosutinib
+∞
10.4
10
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.4
10
*
RS220
NOMESCO Finland
NA
6.9
10.4
25
37
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
32.9
10.3
13
*
ED1AA
NOMESCO Finland
Mandipular X-ray examination
19.0
10.3
15
8
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
23.7
10.3
14
6
HAB40
NOMESCO Finland
Wedge excision of mammary gland
13.3
10.2
17
13
XG410
NOMESCO Finland
Flow-volume spirometry
3.2
10.0
51
164
PJA10
NOMESCO Finland
Exploration of lymph nodes
14.8
10.0
16
11
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
10.0
44
127
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.3
9.9
29
56
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
12.3
9.9
17
14
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
26.3
9.8
13
5
H26.3
ICD-10 Finland
Drug-induced cataract
20.3
9.8
14
7
L01AA02
ATC
chlorambucil; oral
55.6
9.7
11
*
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
55.6
9.7
11
*
B02AA02
ATC
tranexamic acid; systemic
2.1
9.6
109
548
D75.2
ICD-10 Finland
Essential thrombocytosis
8.5
9.6
20
24
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.7
9.5
41
116
ZX070
NOMESCO Finland
Intensity modified radiotherapy
101.0
9.4
10
*
B74
ICPC
Malignant neoplasm blood other
101.0
9.4
10
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
101.0
9.4
10
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
9.4
9
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
9.4
9
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
+∞
9.4
9
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
9.4
9
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
9.4
9
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
9.4
9
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
9.4
9
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
9.4
9
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
21.9
9.4
13
6
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
9.2
171
1032
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.2
9.1
33
80
J01FF01
ATC
clindamycin; systemic
1.7
9.1
234
1563
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
9.0
404
3102
SPAT1074
SPAT
Venesection
18.8
8.9
13
7
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
8.9
67
277
ZX100
NOMESCO Finland
Oral
6.9
8.9
21
31
A98
ICPC
Health maint/preventive medicine
0.6
8.8
675
7522
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
8.7
176
1089
B37.7
ICD-10 Finland
Candidal sepsis
50.5
8.7
10
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
8.6
61
242
1XC02
NOMESCO Finland
NA
16.5
8.6
13
8
N05CF01
ATC
zopiclone; oral
1.6
8.5
277
1961
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
8.5
154
920
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
90.8
8.4
9
*
Z51.0
ICD-10 Finland
Radiotherapy session
90.8
8.4
9
*
M87.3
ICD-10 Finland
Other secondary osteonecrosis
90.8
8.4
9
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
90.8
8.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.3
8
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
B59
ICD-10 Finland
Pneumocystosis
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
C92
ICD-10 Finland
Myeloid leukaemia
+∞
8.3
8
*
C91.7
ICD-10 Finland
Other lymphoid leukaemia
+∞
8.3
8
*
L01EA04
ATC
bosutinib; oral
+∞
8.3
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.3
8
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
8.3
8
*
L03AA10
ATC
lenograstim; parenteral
+∞
8.3
8
*
1BC01
NOMESCO Finland
NA
+∞
8.3
8
*
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
+∞
8.3
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
8.3
8
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
9.6
8.3
16
17
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.0
8.2
47
164
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
14.6
8.2
13
9
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
6.6
8.2
20
31
TPX15
NOMESCO Finland
Removal of vascular injection port
33.7
8.1
10
*
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
10.1
8.0
15
15
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
10.1
8.0
15
15
A07AA09
ATC
vancomycin; oral
5.9
8.0
21
36
WZC30
NOMESCO Finland
Teaching
2.2
7.9
82
399
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.7
7.9
25
54
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
7.8
84
414
A79
ICPC
Malignancy NOS
45.4
7.7
9
*
2AX05
NOMESCO Finland
NA
45.4
7.7
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.7
7.7
32
89
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
7.5
7.7
17
23
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.5
7.7
57
235
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
25.2
7.6
10
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.7
7.5
31
86
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.0
7.5
41
141
H02AB07
ATC
prednisone; oral
1.8
7.5
125
729
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
80.7
7.4
8
*
174
Kela drug reimbursment
Ruxolitinib
80.7
7.4
8
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
11.0
7.3
13
12
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
+∞
7.3
7
*
153
Kela drug reimbursment
Lenalidomid
+∞
7.3
7
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
7.3
7
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
7.3
7
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
7.3
7
*
373
Kela drug reimbursment
Ponatinib
+∞
7.3
7
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
7.3
7
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
+∞
7.3
7
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
7.3
7
*
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
7.4
7.2
16
22
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.9
7.2
22
46
ZZR00
NOMESCO Finland
Flap of skin
12.1
7.1
12
10
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
12.1
7.1
12
10
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.1
7.1
36
118
XQ848
NOMESCO Finland
Dermatological photography
4.8
7.0
22
47
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.9
7.0
27
71
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.1
6.9
25
62
L01AA01
ATC
cyclophosphamide; systemic
11.0
6.8
12
11
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
40.3
6.8
8
*
N06DX01
ATC
memantine; oral
0.3
6.7
10
382
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.5
6.7
16
25
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
12.3
6.6
11
9
RS221
NOMESCO Finland
NA
4.4
6.6
22
51
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.2
6.5
16
26
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
6.5
133
827
C50
ICD-10 Finland
Malignant neoplasm of breast
70.3
6.4
7
*
L01XE18
ATC
[U] ruxolitinib; oral
70.3
6.4
7
*
N89.5
ICD-10 Finland
Stricture and atresia of vagina
70.3
6.4
7
*
XX1AD
NOMESCO Finland
Other CT-examination
70.3
6.4
7
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.4
182
1234
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
8.2
6.3
13
16
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
6.3
8
336
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
6.3
25
68
K61.0
ICD-10 Finland
Anal abscess
4.6
6.3
20
44
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
18.2
6.3
9
5
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
18.2
6.3
9
5
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
18.2
6.3
9
5
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
6.3
88
481
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
6.3
6
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
6.3
6
*
J05AX18
ATC
letermovir; oral
+∞
6.3
6
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
6.3
6
*
L01BB05
ATC
fludarabine; systemic
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
6.3
6
*
B01AC14
ATC
[U] anagrelide; oral
+∞
6.3
6
*
L04AX04
ATC
lenalidomide; oral
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
6.3
6
*
L01XE24
ATC
[U] ponatinib; oral
+∞
6.3
6
*
9109
FHL
Other measure in this category
26.9
6.2
8
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.1
6.1
65
321
R04.0
ICD-10 Finland
Epistaxis
2.1
6.1
69
349
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
6.7
6.0
14
21
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.1
6.0
11
11
L03.9
ICD-10 Finland
Cellulitis, unspecified
4.2
6.0
21
51
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
6.0
127
792
A01AB09
ATC
miconazole; local oral
2.0
6.0
75
395
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.1
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
190
50
47.60
316.96
1.4
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
191
53
45.19
314.28
2.8
2.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
538
688
17.37
307.65
18.6
2.9
u/l
299.9
234.3
4.73
528
645
(21494434) Karyotype in Bone marrow
283
59
68.77
307.65
1.4
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
304
90
49.90
307.65
5.0
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
199
104
24.13
262.87
11.6
5.5
iu/ml
370.7
857.7
0.61
39
12
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
197
108
22.93
254.62
1.5
1.4
u/ml
109.6
108.6
0.05
55
20
(3023520) Reticulocytes [#/volume] in Blood
391
633
9.99
254.08
7.4
2.3
e9/l
65.3
68.3
0.63
313
497
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
181
83
26.89
251.91
4.1
3.4
u/ml
538.1
443.5
0.12
15
12
(3027945) Reticulocytes/100 erythrocytes in Blood
446
853
9.19
250.31
7.6
2.3
%
1.8
1.7
0.61
429
752
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
196
118
20.82
242.31
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
201
128
19.80
241.82
1.4
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
216
165
16.79
236.01
4.3
2.9
g/l
3.7
3.6
0.19
209
155
(3017181) Myelocytes/100 leukocytes in Blood
338
504
10.01
233.35
11.7
4.0
%
1.7
0.7
5.88
206
120
(3045142) Bone marrow Pathology biopsy report
147
49
35.50
227.96
1.7
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
312
449
9.99
220.78
3.1
2.3
g/l
9.5
11.0
6.74
299
411
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
183
119
18.94
217.16
1.4
1.3
u/ml
253.3
237.7
0.20
116
68
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
189
137
17.09
211.76
4.1
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
191
144
16.47
209.35
3.8
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
209
185
14.32
208.48
1.3
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
409
899
7.38
194.98
13.5
5.2
mmol/l
1.0
1.0
0.44
404
812
(3024471) HLA-A [Type]
104
18
65.00
187.72
1.0
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
419
975
7.04
187.59
11.4
2.9
mmol/l
0.8
0.8
1.49
406
904
(3024932) HLA-DR beta [Type]
102
17
67.34
185.28
1.5
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
157
103
18.17
184.65
1.2
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
289
464
8.62
184.07
11.7
3.9
%
1.0
0.5
2.19
139
90
(3004809) Band form neutrophils/100 leukocytes in Blood
138
73
22.06
179.58
10.3
3.2
%
1.3
1.2
0.09
116
56
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
154
103
17.75
179.20
4.2
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
256
368
9.25
178.83
1.6
1.3
g/l
1.2
1.1
0.04
244
339
(3008536) Aspergillus sp Ab [Presence] in Serum
87
10
95.96
166.58
4.3
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
161
6
324.49
163.33
1.1
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
277
483
7.77
162.31
12.7
4.0
%
0.5
0.0
1.44
195
109
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
174
176
11.95
157.61
1.7
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
243
383
8.26
155.60
1.5
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
85
14
66.78
154.30
5.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
260
457
7.53
150.42
12.4
4.2
%
5.0
0.9
2.12
152
96
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
84
18
51.24
144.88
1.3
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
79
16
53.91
137.77
1.3
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
134
113
13.70
135.94
1.3
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
108
61
19.92
135.71
11.4
3.6
—
—
—
0
0
(44790047)
110
67
18.51
133.31
2.2
1.5
—
—
—
0
0
(44790049)
110
67
18.51
133.31
2.2
1.5
—
—
—
0
0
(44790048)
110
67
18.51
133.31
2.2
1.5
—
—
—
0
0
(44806118)
110
67
18.51
133.31
2.2
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
117
84
15.81
130.16
8.9
7.2
mg/l
10.2
11.7
2.31
112
78
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
105
61
19.30
130.12
4.8
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
201
315
7.88
128.04
1.9
1.8
g/l
1.4
1.5
0.56
177
271
(42870588) Differential panel, method unspecified - Blood
558
2171
4.98
127.59
24.8
5.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
105
70
16.80
121.38
4.9
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
276
635
5.78
119.11
1.7
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
79
28
30.76
118.85
5.6
1.5
e6/l
413.2
1037.8
1.99
43
12
(40765096) Chromosome analysis panel by Banding
66
12
59.16
117.28
1.2
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
491
1824
4.62
116.80
9.2
2.5
umol/l
325.2
7872.8
7.36
469
1550
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
86
44
21.45
112.61
1.8
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
249
548
5.85
112.34
2.3
1.7
g/l
65.4
67.5
3.92
241
489
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
291
738
5.30
111.69
1.7
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
115
109
11.91
107.74
1.9
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
90
56
17.70
107.54
10.5
3.1
%
45.5
52.2
0.93
64
39
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
65
17
41.06
106.56
6.8
2.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
626
2972
4.45
102.21
23.3
5.5
%
0.7
0.7
0.52
611
2747
(3019069) Monocytes/100 leukocytes in Blood
638
3088
4.46
100.93
25.6
5.7
%
10.0
8.7
5.33
622
2861
(3006504) Eosinophils/100 leukocytes in Blood
635
3072
4.43
100.30
24.0
5.5
%
2.4
3.0
9.87
621
2830
(4035726)
135
175
8.87
100.25
1.7
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
99
83
13.24
100.16
2.1
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
89
64
15.29
98.44
2.4
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
641
3160
4.37
97.61
24.5
5.6
%
31.6
27.4
11.65
624
2918
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
85
57
16.33
97.60
5.4
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
85
57
16.33
97.60
5.4
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
85
57
16.33
97.60
5.4
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
70
32
23.59
95.81
6.4
1.9
e9/l
1.2
1.0
0.40
31
17
(3018677) aPTT in Platelet poor plasma by Coagulation assay
333
1062
4.34
93.80
5.0
2.0
s
29.1
30.0
1.94
324
1020
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
61
21
31.03
92.31
6.6
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
61
21
31.03
92.31
6.6
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
61
21
31.03
92.31
6.6
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
84
64
14.34
89.80
4.1
2.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
617
3125
3.95
86.35
21.9
5.4
%
49.8
57.6
29.94
599
2897
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
204
470
5.29
85.87
3.5
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
63
29
23.24
85.86
6.5
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
63
29
23.24
85.86
6.5
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
63
29
23.24
85.86
6.5
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
63
29
23.24
85.86
6.5
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
78
58
14.60
84.47
1.2
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
55
19
30.72
83.02
7.4
1.5
e9/l
0.3
0.2
0.53
55
19
(3023368) Bacteria identified in Blood by Culture
444
1864
3.67
81.86
16.1
4.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
628
3293
3.84
81.64
26.1
4.0
umol/l
11.5
11.9
0.42
612
3076
(3013650) Neutrophils [#/volume] in Blood by Automated count
670
3675
4.01
81.10
42.7
6.3
e9/l
3.5
4.4
3.91
630
3176
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
70
46
16.39
81.02
1.6
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
68
43
16.99
80.26
1.3
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
639
3431
3.81
79.11
24.5
5.5
e9/l
0.2
0.2
9.01
590
2996
(46235355) HIV 1 and 2 tests - Meaningful Use set
289
929
4.07
78.85
1.8
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
623
3305
3.73
78.28
21.2
5.3
e9/l
0.6
0.6
0.21
577
2836
(3006315) Basophils [#/volume] in Blood
624
3321
3.72
77.84
21.2
5.3
e9/l
0.0
0.0
3.74
578
2858
(3020779) Urea [Moles/volume] in Serum or Plasma
221
587
4.64
77.77
9.2
7.0
mmol/l
8.4
10.5
4.05
215
555
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
327
1158
3.83
77.39
4.4
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
86
10.93
77.22
1.8
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
626
3390
3.64
74.82
21.6
5.4
e9/l
1.9
1.9
0.24
585
2968
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
43
12
37.54
68.89
8.7
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
84
96
9.53
68.33
2.1
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
79
84
10.19
67.78
2.0
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
55
32
18.21
67.47
2.1
2.3
%
38.2
41.1
0.19
16
13
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
120
212
6.36
66.61
3.3
3.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
222
673
4.03
64.56
14.1
2.5
umol/l
7.9
8.4
0.14
214
581
(3000093) Morphology [Interpretation] in Blood Narrative
67
62
11.57
63.22
1.2
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
344
1404
3.31
63.21
17.7
4.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
48
24
21.04
62.97
3.7
2.2
%
17.8
13.8
0.34
19
11
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
92
130
7.75
62.87
1.3
1.2
u/l
151.9
20.0
3.52
82
116
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
39
11
36.98
62.21
1.8
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
414
1918
3.10
60.72
13.2
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
110
196
6.24
60.39
2.4
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
75
87
9.30
60.20
5.0
1.9
pg
34.0
33.3
0.48
75
87
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
65
7
99.82
59.70
1.7
2.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
593
3384
3.11
59.29
20.4
5.8
mmol/l
1.2
1.2
1.08
513
2872
(3004588) Protein electrophoresis panel - Serum or Plasma
177
484
4.29
58.93
1.9
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
53
40
14.00
56.62
1.5
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
53
40
14.00
56.62
1.5
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
124
262
5.31
56.61
2.9
1.8
ug/l
6.4
1.5
0.78
118
229
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
236
817
3.54
55.69
3.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
236
820
3.52
55.35
2.9
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
303
1234
3.17
54.68
1.6
1.3
g/l
2.2
2.6
4.39
261
730
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
335
1448
3.06
54.44
3.2
1.7
mg/l
3.2
1.2
3.71
290
1089
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
546
3077
2.90
54.00
17.4
5.5
mmol/l
1.2
1.2
1.09
521
2722
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
49
36
14.32
53.11
2.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
45
29
16.26
52.32
2.8
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
45
29
16.26
52.32
2.8
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
48
36
14.01
51.40
2.7
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
33
11
31.08
49.99
4.3
1.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
33
11
31.08
49.99
4.3
1.8
%
12.5
5.0
2.86
33
11
(3036489) Thrombin time
109
230
5.24
49.66
4.2
2.2
s
21.7
21.3
0.34
103
205
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
93
173
5.87
48.61
1.6
2.2
mg/l
26.7
11.9
1.49
81
159
(3024561) Albumin [Mass/volume] in Serum or Plasma
511
2889
2.72
48.43
15.2
3.8
g/l
33.9
35.6
8.60
498
2647
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
41
26
16.46
48.01
1.5
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
393
1964
2.74
47.39
15.4
3.1
ph
7.4
7.4
0.35
77
315
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
511
2910
2.70
47.39
19.0
3.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
324
1474
2.85
46.76
12.3
2.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
39
24
16.92
46.33
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
228
874
3.14
44.61
2.5
2.6
%
30.3
23.3
5.54
188
749
(3033658) Prothrombin time (PT) actual/Normal
337
1597
2.75
44.59
10.7
3.5
%
85.2
85.9
0.19
327
1551
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
73
117
6.69
44.23
8.1
3.4
%
48.9
58.8
5.64
73
117
(3004789) Transferrin [Mass/volume] in Serum or Plasma
236
947
3.01
42.40
2.4
2.5
g/l
2.2
2.3
4.49
225
882
(3022948) Iron [Moles/volume] in Serum or Plasma
253
1062
2.91
41.82
2.4
2.5
umol/l
15.5
13.1
4.34
244
976
(40760888) Immunoglobulin light chains.free panel - Serum
73
146
5.34
35.11
2.9
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
31
21
15.24
34.93
2.2
2.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
28
16
18.02
34.31
1.8
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
85
198
4.63
34.18
2.2
1.4
ratio
42.6
1.3
—
5
19
(3034860) Kappa light chains.free [Mass/volume] in Serum
86
203
4.57
34.02
2.7
1.4
mg/l
44.7
47.9
0.12
74
166
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
61
110
5.87
32.77
2.0
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
84
204
4.43
32.03
2.8
1.4
mg/l
26.3
35.7
1.93
72
168
(3028679) Herpes simplex virus Ab [Presence] in Serum
32
27
12.24
31.77
1.2
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
24
12
20.51
31.14
1.3
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
24
12
20.51
31.14
1.5
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
50
79
6.63
30.60
5.0
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
215
959
2.62
30.56
2.2
2.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
62
122
5.38
30.32
1.7
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
50
80
6.55
30.24
5.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
50
80
6.55
30.24
5.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
50
80
6.55
30.24
5.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
50
80
6.55
30.24
5.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
50
80
6.55
30.24
5.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
35
38
9.53
29.30
1.2
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
458
2875
2.18
29.19
4.3
2.7
ug/l
532.7
129.8
8.69
439
2615
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
27
20
13.88
28.90
1.5
2.1
—
2024630.0
—
0
5
(3013727) Leukocytes other/100 leukocytes in Blood
35
8
45.35
28.86
8.4
3.0
%
41.2
64.1
—
35
8
(3014148) Varicella zoster virus Ab [Titer] in Serum
43
62
7.23
28.61
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
183
785
2.66
27.94
3.4
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
45
70
6.71
27.93
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
96
287
3.62
27.40
6.8
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
360
2096
2.18
27.34
6.3
2.7
u/l
34.2
34.7
0.06
348
1986
(40758558) Short blood count panel - Blood
287
1529
2.27
27.12
30.5
4.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
585
4119
2.15
26.77
12.4
4.6
mmol/l
6.8
6.8
0.05
570
3841
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
63
141
4.72
26.53
4.3
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
31
6
53.36
26.35
1.3
3.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
444
2851
2.08
25.60
10.5
10.4
inr
1.2
1.3
1.21
123
804
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
32
37
8.92
25.53
1.5
6.0
—
34.9
—
0
10
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
319
1815
2.16
25.30
2.5
2.1
mg/l
3.0
3.0
0.08
274
1522
(3007853) Bacteria identified in Skin by Aerobe culture
178
791
2.55
25.09
1.9
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
87
259
3.60
24.94
1.8
1.4
g/l
9.8
11.0
1.35
72
218
(3003694) ABO and Rh group [Type] in Blood
296
1647
2.17
24.75
2.2
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
392
2427
2.07
24.73
4.7
3.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
28
5
57.66
24.14
1.4
2.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
277
3.45
23.83
1.8
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
277
3.45
23.83
1.8
1.4
g/l
3.6
3.9
1.34
64
200
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
277
3.45
23.83
1.8
1.4
g/l
7.0
7.5
1.39
64
206
(3035933) Granulocytes/100 leukocytes in Blood
22
16
14.06
23.71
1.2
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
351
2127
2.05
23.11
3.8
2.3
u/l
51.3
57.9
3.31
330
1953
(3000012) Reticulocyte production index
29
34
8.77
22.87
2.0
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
116
434
2.91
22.77
2.9
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
85
265
3.43
22.68
2.9
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
442
2946
1.96
21.85
34.1
8.2
e9/l
0.1
0.0
0.88
388
2387
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
672
5208
2.07
21.03
32.3
5.4
u/l
83.3
76.4
3.67
658
4793
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
129
532
2.66
20.98
2.8
2.1
g/l
0.2
0.2
0.05
116
478
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
260
3.32
20.62
1.9
1.4
g/l
3.2
3.1
0.43
64
202
(3028433) Virus identified in Specimen by Culture
23
23
10.23
20.33
1.0
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
48
107
4.68
20.29
2.6
2.1
u/l
22463.6
3144.3
0.75
15
36
(3015377) Calcium [Moles/volume] in Serum or Plasma
351
2206
1.95
20.22
5.6
2.1
mmol/l
2.3
2.3
5.39
322
1817
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
32
49
6.73
20.12
2.5
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
108
429
2.72
18.85
1.6
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
17
11.39
18.03
1.4
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
51
133
4.00
17.63
1.4
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
93
354
2.81
17.58
3.5
1.4
ug/l
15.4
3.7
0.51
76
268
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
58
170
3.57
16.98
1.3
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
30
7.84
16.61
2.5
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
23
30
7.84
16.61
2.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
65
212
3.22
16.10
3.4
3.0
u/ml
0.3
0.4
0.35
37
128
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
107
460
2.50
15.84
6.2
3.8
mmol/l
0.8
1.8
2.31
86
339
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
67
229
3.08
15.35
1.7
1.4
g/l
0.3
0.5
0.30
61
198
(3044290) Cell count panel - Cerebral spinal fluid
48
133
3.75
15.26
3.0
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
108
475
2.44
15.22
6.3
3.8
ph
7.4
7.4
0.09
13
49
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
21
28
7.65
14.88
10.2
1.3
u/l
227.4
206.1
0.38
21
28
(3002582) Erythrocytes [#/volume] in Urine
311
2037
1.79
14.72
4.6
3.0
e6/l
41.1
99.6
1.00
251
1565
(40757373) Influenza virus identified in Isolate
16
15
10.84
14.68
1.1
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
108
483
2.40
14.65
6.4
3.8
kpa
5.1
5.2
0.89
102
451
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
38
6.46
14.61
2.5
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
35
6.71
14.52
3.3
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
248
1523
1.86
14.45
1.9
1.8
nmol/l
1242.2
1170.3
0.56
220
1147
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
50
152
3.42
13.86
1.2
1.3
miu/ml
269.9
243.9
0.11
11
67
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
53
169
3.27
13.63
1.5
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
63
223
2.96
13.58
1.6
1.4
g/l
37.5
37.4
0.00
58
186
(40765089) Chromosome analysis panel - Blood by G-banded
14
12
11.83
13.55
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
5
34.59
13.53
1.4
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
307
2059
1.74
13.08
2.6
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
104
484
2.29
12.86
1.5
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
29
63
4.72
12.66
2.7
1.1
—
—
—
0
0
(3019225) pH of Specimen
134
695
2.09
12.64
12.4
3.7
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
12
0
+∞
12.53
1.2
0.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
85
367
2.45
12.43
7.1
3.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
98
452
2.31
12.36
3.3
2.9
e9/l
5.3
4.1
0.37
76
330
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
49
159
3.20
12.26
3.1
1.2
e6/l
8.3
57.8
0.77
39
133
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
49
159
3.20
12.26
3.1
1.3
e6/l
42.5
912.6
0.74
41
137
(3025941) Bacteria identified in Stool by Culture
80
340
2.48
12.10
1.6
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
308
2107
1.69
12.01
4.0
3.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
22
39
5.75
11.99
3.0
2.5
u/ml
997.2
1141.4
0.16
22
39
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
15
5
30.45
11.67
1.7
4.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
557
4466
1.62
11.28
5.8
4.4
e6/l
163.9
2547.1
1.60
15
72
(3019832) Treponema pallidum Ab [Presence] in Serum
92
430
2.27
11.24
1.5
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
22
42
5.34
11.10
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
273
1853
1.67
10.75
4.6
2.9
e6/l
0.4
0.4
0.01
215
1391
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46
156
3.05
10.71
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46
156
3.05
10.71
1.5
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
268
1813
1.67
10.68
1.9
1.5
nmol/l
19.3
20.8
0.94
250
1533
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
50
179
2.90
10.59
2.6
1.3
mg/l
497.9
505.3
0.05
50
169
(3018095) Leukocytes [#/volume] in Urine
329
2353
1.62
10.48
5.4
3.5
e6/l
49.2
96.9
1.55
260
1679
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
324
2311
1.62
10.42
3.7
3.0
ng/l
1490.7
1610.2
0.16
301
1968
(3009214) Lutropin [Units/volume] in Serum or Plasma
42
138
3.14
10.32
2.5
1.5
u/l
12.8
7.4
0.95
37
114
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
8
19.03
10.28
2.2
2.0
—
—
—
0
0
(4212803)
14
6
23.66
10.26
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
75
3.96
10.18
2.9
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
176
1075
1.79
10.06
4.5
2.8
e6/l
2.5
2.3
0.11
100
586
(1616796) Gas panel - Central venous blood
39
125
3.21
9.98
3.8
3.8
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
9
16.92
9.89
1.3
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
261
1788
1.64
9.77
4.7
2.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
222
1459
1.69
9.75
5.0
3.9
ng/l
86.0
412.9
4.54
188
1182
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
32
92
3.57
9.69
1.1
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
11
10.11
9.56
3.8
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
72
325
2.32
9.54
7.2
3.8
mmol/l
24.7
24.3
0.39
65
294
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
626
7118
0.62
9.53
5.2
5.2
mmol/l
2.5
2.7
4.02
591
6500
(3028308) Erythrocytes [#/volume] in Pleural fluid
24
57
4.30
9.42
1.6
1.4
e6/l
83687.4
47824.8
0.19
14
32
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
407
3116
1.55
9.40
2.3
2.0
pmol/l
90.0
93.8
0.89
288
1607
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
35
109
3.30
9.39
1.2
1.1
—
—
—
0
0
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
9
0
+∞
9.39
5.3
0.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
139
806
1.85
9.38
10.1
7.7
kpa
11.6
11.4
0.16
131
770
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
139
806
1.85
9.38
10.1
7.7
kpa
4.9
5.1
1.48
132
770
(3023199) Leukocytes [#/volume] in Pleural fluid
26
66
4.02
9.37
1.6
1.3
e6/l
2168.9
1807.6
0.21
20
46
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
30
5.75
9.30
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
17
30
5.75
9.30
1.8
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
138
806
1.84
9.09
10.7
7.7
mmol/l
1.5
1.3
0.19
103
626
(3023410) Appearance of Cerebral spinal fluid
26
68
3.91
9.01
3.8
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
127
725
1.87
8.99
11.1
8.1
%
95.7
95.0
0.48
120
699
(3002032) Base excess in Venous blood by calculation
121
682
1.89
8.91
4.9
3.5
mmol/l
2.1
2.1
0.01
97
560
(3012441) Differential panel - Pleural fluid
23
57
4.11
8.56
1.3
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
20
45
4.52
8.39
1.4
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
92
482
2.01
8.38
9.8
7.9
mmol/l
24.5
24.6
0.08
87
454
(3006184) Hemoglobin [Mass/volume] in Capillary blood
41
151
2.80
8.28
1.9
2.1
g/l
122.1
132.9
1.36
30
116
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
34
114
3.06
8.11
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
209
1412
1.62
8.08
3.4
2.4
e6/l
5.1
5.5
0.19
191
1222
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
51
4.19
8.03
1.3
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
92
495
1.95
7.77
6.9
5.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
39
145
2.76
7.76
2.4
1.3
iu/l
19.3
22.5
0.31
32
125
(21494890) Protein electrophoresis panel - 24 hour Urine
22
58
3.86
7.56
1.6
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
613
6900
0.67
7.37
4.9
4.6
mmol/l
1.3
1.4
14.95
575
6294
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
7
0
+∞
7.30
3.0
0.0
ng/l
8.2
—
—
7
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
7
15.87
7.24
3.8
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
7
15.87
7.24
3.8
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
7
15.87
7.24
3.8
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
17
38
4.54
7.20
1.2
1.2
ug/l
17.6
14.4
0.33
17
38
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
306
2302
1.49
7.19
3.9
2.2
u/l
158.1
243.4
1.47
295
2153
(3026782) Osmolality of Urine
194
1328
1.58
7.01
4.0
2.5
mosm/kgh2o
546.4
552.6
0.14
180
1094
(3010813) Leukocytes [#/volume] in Blood
717
7793
0.64
6.88
73.9
19.2
e9/l
8.5
6.8
0.97
700
7515
(3000963) Hemoglobin [Mass/volume] in Blood
717
7793
0.64
6.88
74.2
19.3
g/l
116.4
136.2
99.37
706
7633
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
172
1150
1.61
6.85
4.2
2.6
e6/l
1.7
1.1
0.64
101
661
(3026361) Erythrocytes [#/volume] in Blood
717
7791
0.64
6.83
73.8
19.1
e12/l
3.9
4.5
86.09
700
7509
(3035941) MCH [Entitic mass]
717
7790
0.64
6.81
73.5
19.0
pg
31.0
30.4
13.51
708
7631
(3007461) Platelets [#/volume] in Blood
717
7789
0.64
6.79
73.9
19.1
e9/l
191.1
244.8
35.81
702
7538
(3024731) MCV [Entitic volume]
717
7788
0.64
6.77
73.6
19.1
fl
93.5
91.2
22.11
708
7630
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
94
3.04
6.70
1.1
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
9
12.35
6.59
3.8
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
25
5.26
6.50
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
11
18
6.17
6.44
9.3
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
66
3.39
6.30
1.4
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
22
5.51
6.30
1.2
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
0
+∞
6.25
1.2
0.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
113
695
1.71
6.20
3.8
3.1
ng/l
220.4
239.9
0.27
106
649
(3000570) Elastase.pancreatic [Mass/mass] in Stool
40
170
2.41
6.13
1.4
1.4
ug/g
245.4
305.7
1.04
24
96
(3013707) Erythrocyte sedimentation rate by Westergren method
599
5206
1.43
6.11
5.9
4.1
mm/h
19.4
12.1
13.62
564
4755
(3052851) Hemolysis interference index of Serum or Plasma
43
190
2.32
6.05
4.5
3.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
628
6963
0.69
6.03
5.2
4.6
mmol/l
4.3
4.5
7.48
598
6391
(3012501) Base excess in Blood by calculation
34
136
2.56
5.92
4.6
4.1
mmol/l
2.6
2.8
0.10
22
89
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
591
6616
0.70
5.91
6.0
6.2
mmol/mol
39.8
40.4
0.94
552
6095
(3000991) Gas panel - Venous blood
95
565
1.76
5.87
12.8
7.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
98
589
1.74
5.84
9.8
6.6
mmol/l
1.4
1.5
0.02
93
560
(3047189) Immunofixation for 24 hour Urine
11
20
5.55
5.81
2.1
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
60
311
1.99
5.67
1.2
1.6
—
14.3
—
0
9
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
95
571
1.74
5.66
2.7
2.1
u/l
29.3
123.8
0.56
83
469
(3019420) Tryptase [Mass/volume] in Serum or Plasma
15
37
4.10
5.64
3.5
1.8
ug/l
16.0
14.6
0.07
15
32
(4062490)
20
61
3.33
5.61
1.5
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
133
876
1.61
5.60
1.3
1.3
titre
504.8
557.7
0.15
29
195
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
195
2.21
5.30
1.4
1.6
iu/ml
0.2
0.2
—
8
35
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
74
3.02
5.28
1.2
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
5
0
+∞
5.21
12.4
0.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
629
6919
0.71
5.14
6.0
4.7
mmol/l
6.1
6.0
0.92
583
6223
(3047181) Lactate [Moles/volume] in Blood
46
225
2.10
5.10
8.5
8.1
mmol/l
1.3
1.3
0.12
41
202
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
40
3.80
5.10
1.1
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
12
27
4.49
5.04
1.5
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
354
2882
1.37
4.96
3.8
3.9
ng/l
63.1
69.6
0.06
277
2062
(3028192) IgG subclass 2 [Mass/volume] in Serum
19
61
3.16
4.93
1.5
1.3
g/l
2.5
2.6
0.06
14
40
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
61
3.16
4.93
1.5
1.3
g/l
5.6
7.4
0.92
13
40
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
61
3.16
4.93
1.5
1.3
g/l
0.3
0.4
0.22
12
40
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
63
349
1.86
4.93
16.5
12.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
10
9.07
4.79
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
52
3.31
4.76
1.4
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
13
33
3.98
4.72
1.6
1.3
u/l
3.5
12.1
—
8
14
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
5
14.09
4.58
3.1
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
30
4.04
4.44
8.5
2.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
26
4.27
4.36
1.0
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
95
2.57
4.32
2.2
1.7
g/l
0.9
1.0
0.12
19
70
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
59
335
1.81
4.30
3.2
3.0
pmol/l
4.5
4.5
0.09
52
287
(40761511) CBC panel - Blood by Automated count
673
7263
0.73
4.23
39.7
12.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
36
3.65
4.21
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
27
4.11
4.17
1.2
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
29
128
2.31
4.16
2.7
2.8
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
29
129
2.29
4.09
2.7
2.4
%
15.7
16.4
0.38
20
64
(3037467) Urinalysis macro (dipstick) panel - Urine
538
4749
1.32
4.07
6.0
4.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
10
8.06
4.06
1.9
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
37
3.55
4.06
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
37
3.55
4.06
1.2
1.0
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
11
28
3.96
3.98
2.4
2.2
mg/l
57.3
69.6
0.28
11
22
(3020876) Protein [Mass/time] in 24 hour Urine
16
53
3.05
3.98
1.6
1.7
—
1.7
—
0
5
(40761535) Cells panel - Urine sediment
94
619
1.58
3.97
3.1
3.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
38
3.46
3.91
1.3
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
5
12.07
3.76
3.3
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
5
12.07
3.76
1.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
90
2.48
3.74
1.5
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
14
45
3.14
3.66
1.4
1.1
mg/l
27.1
35.9
0.92
14
38
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
35
177
2.02
3.63
3.5
1.5
u/ml
55.3
23.5
0.57
35
169
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
35
3.46
3.62
3.8
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
49
279
1.80
3.58
1.8
2.1
u/l
35.6
38.9
0.56
42
235
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
9
7.83
3.56
2.1
6.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
6
10.05
3.50
1.0
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
52
2.92
3.47
1.7
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
65
2.65
3.31
1.2
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
535
5876
0.79
3.15
64.0
17.3
g/l
332.2
332.7
0.59
530
5817
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
19
79
2.43
3.15
4.4
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
173
1.94
3.13
1.3
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
20
4.53
3.12
1.6
1.8
umol/l
29.4
28.6
—
9
20
(3009871) Measles virus Ab [Titer] in Serum
9
20
4.53
3.12
1.9
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
56
346
1.66
3.10
4.4
3.6
%
46.7
47.9
0.12
56
339
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
166
1283
1.36
3.07
3.7
2.1
mmol/l
2.4
2.4
0.20
155
1097
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
5
10.04
2.98
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
17
4.74
2.92
4.5
2.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
200
1.83
2.89
1.2
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
13
5.42
2.87
1.3
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
7
13
5.42
2.87
1.1
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
620
6663
0.79
2.85
5.4
4.1
mmol/l
1.5
1.3
3.91
587
6030
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
201
1.82
2.85
1.2
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
332
2846
1.26
2.82
2.8
2.3
nmol/l
75.1
77.4
0.79
309
2474
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
6
8.37
2.75
8.4
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
520
0.54
2.74
1.9
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
36
204
1.80
2.73
1.2
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
10
6.03
2.70
1.3
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
79
2.30
2.69
1.5
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
705
7445
0.77
2.68
37.7
9.0
u/l
27.5
26.2
1.31
685
7116
(1761868) Lipid panel - Serum or Plasma
188
2305
0.77
2.65
3.5
3.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
10
32
3.15
2.65
1.9
1.5
u/field
1.8
4.2
—
5
24
(40768443) Skin Pathology biopsy report
42
256
1.67
2.49
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
48
303
1.62
2.49
1.3
1.2
—
—
—
0
0
(4027681)
11
39
2.84
2.48
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
39
2.84
2.48
1.1
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
201
1644
1.28
2.48
1.6
1.7
pmol/l
74699250.6
23994465.2
0.30
166
1342
(3001019) Free T4 and TSH panel - Serum or Plasma
10
252
0.39
2.43
2.7
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
27
3.36
2.39
2.8
2.0
nmol/l
6.4
3.3
—
9
27
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
43
268
1.63
2.36
2.8
2.3
ug/l
151.3
456.5
1.11
38
249
(3013512) EKG study
252
2134
1.25
2.31
5.0
4.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
77
551
1.43
2.27
4.1
4.0
ng/l
83.7
90.8
0.40
72
483
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
60
2.35
2.22
1.4
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
49
727
0.66
2.20
1.7
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
156
1916
0.78
2.20
2.3
1.6
mmol/l
1.9
1.4
2.30
141
1604
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
51
338
1.54
2.19
16.1
9.6
mmol/l
24.3
24.5
0.17
46
310
(21494755) Public health laboratory ask at order entry panel
32
522
0.60
2.18
1.2
1.4
—
—
—
0
0
(3020891) Body temperature
47
308
1.55
2.13
6.8
4.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
102
1.98
2.11
3.4
2.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
20
3.52
2.06
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
86
640
1.38
2.05
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
73
529
1.41
2.03
4.6
3.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
10
38
2.65
2.01
1.4
2.0
mmol/l
9.8
10.0
—
10
31
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
359
0.55
1.96
1.5
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
11
4.56
1.94
1.4
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
11
4.56
1.94
1.2
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
16
3.77
1.93
1.8
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
40
2.52
1.84
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
17
3.55
1.84
2.5
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
153
1.72
1.81
1.2
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
379
3413
1.19
1.80
4.0
3.6
estimate
0.0
0.0
0.00
71
556
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
608
6431
0.84
1.73
5.2
4.6
mu/l
2.0
2.1
0.37
570
5817
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
186
2182
0.82
1.73
3.8
3.7
%
21.5
24.2
1.53
89
1007
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
474
4365
1.18
1.70
4.2
3.0
u/l
69.9
46.1
3.94
444
4026
(3027273) Bicarbonate [Moles/volume] in Venous blood
54
385
1.43
1.68
3.3
3.1
mmol/l
24.6
25.4
0.97
54
369
(3035350) Ketones [Presence] in Urine by Test strip
373
3370
1.18
1.68
4.0
3.6
estimate
0.0
0.0
0.00
77
568
(3035637) Corticotropin [Mass/volume] in Plasma
12
55
2.20
1.68
1.3
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
372
3366
1.18
1.63
5.4
4.9
estimate
0.0
0.0
0.50
76
559
(3003327) Ova and parasites identified in Stool by Light microscopy
30
190
1.60
1.61
1.5
1.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
14
3.58
1.61
3.2
7.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
14
3.58
1.61
1.6
3.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
91
1.88
1.61
1.1
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
25
151
1.67
1.61
3.0
3.8
mg/l
38.5
24.2
1.48
18
107
(3048689) Calprotectin [Mass/mass] in Stool
95
747
1.30
1.61
1.9
2.2
ug/g
154.8
139.8
0.14
70
580
(3034770) Mitochondria Ab [Titer] in Serum
31
200
1.57
1.56
1.1
1.2
—
715.0
—
0
6
(3051611) Lipemic interference index of Serum or Plasma
12
57
2.12
1.55
8.8
2.8
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
13
64
2.05
1.54
1.1
1.2
nmol/l
394.6
376.3
—
8
55
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
33
2.44
1.54
1.1
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
42
0.00
1.53
0.0
2.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
5
15
3.35
1.52
1.0
1.1
umol/l
2.4
4.7
—
5
15
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
21
2.87
1.50
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
79
1.91
1.50
1.8
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
9
37
2.45
1.48
1.3
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
26
164
1.60
1.44
4.0
3.0
mmol/l
7.8
7.4
0.42
26
159
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
153
0.45
1.44
2.1
1.2
—
—
—
0
0
(4268621)
13
66
1.98
1.44
2.2
2.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
22
2.74
1.43
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
22
2.74
1.43
1.2
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
33
221
1.51
1.43
1.5
1.6
g/l
1.2
1.2
0.26
33
211
(1002224) Polysomnography panel
15
262
0.57
1.40
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
211
2400
0.84
1.39
3.1
3.2
mmol/l
7.7
7.7
0.01
186
2008
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
23
2.62
1.37
1.2
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
23
2.62
1.37
2.3
4.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
23
2.62
1.37
1.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
622
6518
0.86
1.35
41.0
11.9
ml/min/173m2
77.0
78.0
0.49
544
5228
(3029937) Albumin [Presence] in Urine by Test strip
209
1828
1.19
1.35
4.3
3.8
estimate
0.0
0.0
0.88
71
549
(36660697) Celiac disease serology panel - Serum
36
509
0.70
1.34
1.1
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
48
351
1.39
1.34
2.6
2.4
%
0.7
0.7
0.44
48
342
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
90
1.79
1.33
1.0
1.1
—
16.5
—
0
5
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
61
1.98
1.33
1.8
2.0
u/field
1.0
2.3
—
5
25
(3014271) Vancomycin [Susceptibility]
9
43
2.10
1.30
4.6
3.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
212
2397
0.85
1.29
4.0
4.0
mg/mmol
13.5
8.5
0.68
141
1514
(3044927) Protein electrophoresis panel - Urine
16
92
1.75
1.25
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
123
1.64
1.25
1.3
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
111
922
1.23
1.24
3.5
4.8
%
28.4
32.6
3.91
89
603
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
425
3946
1.14
1.23
3.4
2.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
708
7328
0.85
1.22
55.5
16.0
mmol/l
4.0
4.0
0.71
696
7097
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
89
723
1.26
1.21
2.2
2.5
ug/l
4.2
7.5
2.55
78
630
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
128
1504
0.83
1.21
2.8
2.7
ug/l
0.7
0.7
0.05
80
991
(3011397) Hemoglobin [Presence] in Urine by Test strip
187
1637
1.18
1.20
3.7
3.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
101
1.70
1.20
2.1
2.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
225
0.57
1.20
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
64
1.89
1.18
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
20
2.51
1.15
1.0
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
85
692
1.25
1.14
6.3
3.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
96
1.68
1.10
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
160
1.51
1.10
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
31
219
1.43
1.08
2.9
1.8
—
—
—
0
0
(4034850)
16
254
0.62
1.07
8.6
11.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
200
1777
1.16
1.07
3.7
3.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
123
1433
0.84
1.07
1.2
1.3
u/ml
2.3
2.0
0.09
31
390
(3003740) Influenza virus B Ag [Presence] in Specimen
14
82
1.72
1.05
3.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.03
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
34
2.07
1.03
1.0
1.4
nmol/l
114.9
147.7
—
7
34
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
34
2.07
1.03
1.0
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
709
7311
0.87
1.02
50.3
15.9
mmol/l
139.2
139.8
7.25
696
7089
(3002523) Influenza virus A Ag [Presence] in Specimen
14
83
1.70
1.01
3.2
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
91
1.66
1.01
1.3
1.2
u/ml
4.4
6.4
—
5
44
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
172
1.47
1.00
2.5
3.6
nmol/l
0.8
0.8
0.25
16
139
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
38
503
0.74
1.00
1.8
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
43
557
0.76
0.98
1.9
2.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
36
1.95
0.97
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
383
1.30
0.94
2.6
2.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
101
1.59
0.94
2.7
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
116
1004
1.18
0.88
1.5
1.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
16
103
1.56
0.88
2.7
2.4
mmol/l
106.7
104.9
2.05
16
103
(3041354) Potassium [Moles/volume] in Venous blood
16
103
1.56
0.88
2.7
2.4
mmol/l
4.0
4.1
0.72
16
103
(4281824)
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
205
2259
0.88
0.87
3.3
3.3
mg/l
2870.4
213.3
2.59
151
1434
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
14
88
1.60
0.84
1.0
1.1
%
123.0
116.3
0.28
14
81
(3022217) INR in Platelet poor plasma by Coagulation assay
120
1046
1.17
0.84
21.4
28.2
inr
1.2
1.4
1.19
23
150
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
45
1.78
0.84
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
603
6250
0.90
0.82
48.7
14.4
%
35.4
40.0
21.63
383
4208
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
66
546
1.22
0.82
4.0
2.3
ml/min/173m2
65.3
66.4
0.08
34
236
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
25
0.00
0.79
0.0
1.3
—
8.9
—
0
25
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
200
1.36
0.77
1.4
1.4
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
34
1.77
0.76
1.8
1.1
u/l
231.7
568.7
—
6
29
(4010399)
41
514
0.79
0.76
1.6
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
58
480
1.22
0.73
1.3
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
171
0.64
0.72
1.6
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
281
2618
1.11
0.71
4.1
3.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
41
1.71
0.70
1.9
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
204
0.68
0.69
1.5
2.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
61
1.65
0.68
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
103
906
1.15
0.67
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
49
1.64
0.62
1.8
2.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
50
1.61
0.61
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
20
0.00
0.60
0.0
1.1
—
101.8
—
0
14
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
20
0.00
0.60
0.0
2.6
—
347.4
—
0
15
(3037556) Urate [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
23
0.00
0.58
0.0
1.1
—
264.0
—
0
14
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
36
1.67
0.56
2.3
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
31
248
1.26
0.56
2.5
2.4
g/l
0.7
0.3
0.80
17
87
(3028300) Cannabinoids [Presence] in Urine
16
216
0.74
0.54
1.4
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
91
1.43
0.53
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
215
0.74
0.53
1.4
2.0
—
—
—
0
0
(4094501)
14
191
0.73
0.51
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
255
2699
0.92
0.49
4.2
3.9
ug/l
4.1
2.0
0.45
232
2408
(4306422)
13
93
1.40
0.48
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
25
199
1.26
0.48
4.3
4.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
164
1.29
0.47
2.1
2.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
49
1.43
0.46
2.7
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
81
0.62
0.46
1.0
1.0
—
3.0
—
0
32
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
105
956
1.11
0.44
11.8
7.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
18
140
1.29
0.42
1.3
1.6
—
—
—
0
0
(3000492) Spirometry study
67
596
1.13
0.42
1.9
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
70
1.43
0.42
1.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
709
6966
1.08
0.41
55.1
13.2
mg/l
26.6
24.4
1.02
656
5394
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
16
0.00
0.41
0.0
2.7
—
1371.6
—
0
8
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.1
iu/ml
106.4
277.3
—
5
35
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
214
0.79
0.38
1.4
2.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.8
2.0
umol/l
74.2
53.2
—
5
28
(3027944) Amphetamines [Presence] in Urine
17
213
0.79
0.37
1.5
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
81
1.36
0.36
1.2
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
18
144
1.25
0.35
2.6
2.0
pmol/l
175.5
226.6
2.17
18
136
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
144
0.76
0.33
2.3
1.5
—
—
—
0
0
(4146454)
6
87
0.69
0.33
5.0
2.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
90
0.66
0.33
2.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
74
1.36
0.32
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
304
0.85
0.30
1.1
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
93
1.29
0.30
1.4
1.3
nmol/l
0.5
0.7
1.79
12
85
(3032773) Endomysium IgG Ab [Titer] in Serum
7
55
1.27
0.30
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
84
776
1.09
0.29
1.6
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
141
0.78
0.29
1.7
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
8
109
0.73
0.29
1.4
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
76
1.32
0.28
1.3
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
113
1.24
0.26
1.2
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
76
1.19
0.24
1.0
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
491
5003
0.96
0.24
6.1
4.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
1.7
—
0
10
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
15.2
—
0
12
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
43
1.16
0.21
1.2
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
43
1.16
0.21
17.8
12.5
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
13
0.00
0.21
0.0
1.7
—
12.9
—
0
8
(3044007) Cell count panel - Peritoneal fluid
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
14
0.00
0.20
0.0
8.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17
146
1.17
0.19
1.1
1.2
—
27.8
—
0
13
(3005322) IgE [Units/volume] in Serum or Plasma
43
398
1.08
0.17
1.7
1.2
u/ml
508.3
276.8
0.39
35
362
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
81
1.11
0.15
1.3
1.3
nmol/l
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
86
0.81
0.14
1.4
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
160
0.87
0.14
2.6
2.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
96
0.83
0.13
1.1
1.0
g/l
1.5
1.5
—
8
83
(3011288) Drugs identified in Urine by Screen method
12
138
0.87
0.13
2.9
2.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
200
1.10
0.12
1.8
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
158
0.88
0.12
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
231
1.08
0.10
1.5
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
118
1147
1.03
0.10
1.2
1.3
iu/ml
25.4
35.4
0.64
41
361
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
154
1.11
0.10
1.2
1.2
—
9.7
—
0
10
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
87
1.15
0.09
1.5
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
145
0.90
0.09
1.5
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
114
1112
1.03
0.08
1.2
1.3
u/ml
1.6
12.7
6.35
39
418
(3011648) Oxygen content in Venous blood
6
58
1.03
0.08
1.0
1.7
%
9.0
10.8
—
6
58
(3038026) Centromere Ab [Units/volume] in Serum
5
62
0.81
0.08
1.4
1.1
—
89.0
—
0
5
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
64
0.78
0.08
1.2
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
98
1.12
0.07
2.1
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
74
0.81
0.07
2.7
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
245
0.94
0.07
2.0
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
157
1.08
0.07
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
78
760
1.03
0.06
1.6
1.7
%
1.6
1.5
0.19
66
660
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
21
197
1.07
0.06
2.9
1.9
nmol/l
44.4
40.3
0.20
21
186
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
207
1.06
0.06
2.6
2.4
ug/min
407.3
82.3
0.45
12
132
(3019150) Specific gravity of Urine by Refractometry
166
1639
1.02
0.05
4.1
3.9
kg/l
1.0
1.0
1.77
25
245
(3013139) Helicobacter pylori Ag [Presence] in Stool
42
434
0.97
0.05
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
527
5292
0.99
0.04
4.2
3.7
pmol/l
14.9
14.9
0.00
491
4761
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
398
1.03
0.04
1.1
1.2
iu/ml
47.3
115.4
1.96
14
167
(3022621) pH of Urine by Test strip
46
471
0.98
0.03
2.7
2.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
21
201
1.05
0.03
1.2
1.2
—
36.1
—
0
10
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
232
1.04
0.02
1.6
2.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
233
1.03
0.01
1.8
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
28
287
0.97
0.01
2.2
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
38
384
0.99
0.00
3.8
3.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
122
0.98
0.00
1.2
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
19
193
0.98
0.00
1.2
1.2
—
7.8
—
0
27
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
57
0.88
0.00
1.4
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
19
190
1.00
0.00
1.2
1.2
—
3.1
—
0
18
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
51
0.98
0.00
1.8
2.2
%
13.8
13.2
—
5
51
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
16.9
—
0
6
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
61
0.98
0.00
2.2
1.6
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
8.8
—
0
5
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
180
1.00
0.00
1.5
1.7
e6/l
14074.7
13259.6
0.05
11
135
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
6
69
0.87
0.00
1.0
1.5
—
32.6
—
0
5
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
294.0
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
6.9
—
0
6
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
60
1.00
0.00
1.2
1.0
mg/l
326.2
274.6
—
6
53
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
63
0.95
0.00
1.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_MYELOID_LEUKAEMIA_EXALLC – Myeloid leukaemia

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).